1 / 9

MeTA Phase I: Where are we?

This project aims to increase transparency in the selection, regulation, procurement, sale, and distribution of medicines in developing countries. By involving multiple stakeholders, it aims to strengthen governance, improve efficiency, and encourage responsible business practices. Key focus areas include increased access to essential medicines, better supply chain effectiveness, and promoting better governance. Progress includes political commitment, international stakeholder support, and the establishment of an international secretariat.

davidajones
Download Presentation

MeTA Phase I: Where are we?

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MeTA Phase I:Where are we? MeTA

  2. The MeTA Phase I Proposal Purpose To pilot a new multi-stakeholder approach towards increasing transparency around the selection, regulation, procurement, sale and distribution of medicines in developing countries, thereby strengthening governance, improving efficiency, and encouraging innovative and responsible business practices MeTA 07/01/2020 2

  3. 7 Pilot Countries … pioneers, leaders, champions – innovators! MeTA

  4. 3 key stakeholder sectors Public: (ministries – not only Health; health service managers and facilities; regulatory agencies; health and welfare insurance schemes) Private: (manufacturers; wholesalers; distributors; retailers; private practitioners and services; private health insurance; investors) Civil society: (communities, patients, consumers, transparency and rights groups, media, faith-based organisations)

  5. One goal Increased access to essential medicines by poor people by: shifting some decision making power Increasing competitive pressure on suppliers Improving the effectiveness of the supply chain promoting better governance ensuring more appropriate resource allocation encouraging innovative and responsible business practices Increasing the voice of patients and consumers And improving people’s health!

  6. 3 key points of Phase I Country structure and commitment Transparency: disclosure, data collection and analysis Accountability: multi-stakeholder approach and good governance

  7. Key Point 2: Transparency Data Collection and Dissemination Data on the quality and registration status of medicines Data about the availability of medicines Medicines price data Policies concerning the ethical promotion of medicines

  8. Achievements so far 18 months planning and consensus building 7 countries commit politically Growing list of international stakeholders who support the concept International Secretariat in place International Advisory Group underway International launch – “2nd phase of the peaceful revolution in international public health” now underway! MeTA

  9. Thank You MeTA 07/01/2020 9

More Related